Leveraging single-cell profiling in early-phase trials to guide rational therapy development.
Publication
, Journal Article
Louw, J; Jepson, J; Corcoran, AM; Khasraw, M
Published in: Neuro Oncol
March 1, 2026
Duke Scholars
Published In
Neuro Oncol
DOI
EISSN
1523-5866
Publication Date
March 1, 2026
Volume
28
Issue
3
Start / End Page
672 / 674
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
Citation
APA
Chicago
ICMJE
MLA
NLM
Louw, J., Jepson, J., Corcoran, A. M., & Khasraw, M. (2026). Leveraging single-cell profiling in early-phase trials to guide rational therapy development. Neuro Oncol, 28(3), 672–674. https://doi.org/10.1093/neuonc/noaf277
Louw, Julia, Jodie Jepson, Anna M. Corcoran, and Mustafa Khasraw. “Leveraging single-cell profiling in early-phase trials to guide rational therapy development.” Neuro Oncol 28, no. 3 (March 1, 2026): 672–74. https://doi.org/10.1093/neuonc/noaf277.
Louw J, Jepson J, Corcoran AM, Khasraw M. Leveraging single-cell profiling in early-phase trials to guide rational therapy development. Neuro Oncol. 2026 Mar 1;28(3):672–4.
Louw, Julia, et al. “Leveraging single-cell profiling in early-phase trials to guide rational therapy development.” Neuro Oncol, vol. 28, no. 3, Mar. 2026, pp. 672–74. Pubmed, doi:10.1093/neuonc/noaf277.
Louw J, Jepson J, Corcoran AM, Khasraw M. Leveraging single-cell profiling in early-phase trials to guide rational therapy development. Neuro Oncol. 2026 Mar 1;28(3):672–674.
Published In
Neuro Oncol
DOI
EISSN
1523-5866
Publication Date
March 1, 2026
Volume
28
Issue
3
Start / End Page
672 / 674
Location
England
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis